Excorp Medical, Inc. has developed a system for the temporary metabolic support of patients in acute liver failure in a 10-year collaboration with the leading university in liver transplantation and tissue engineering, the University of Pittsburgh, Thomas E. Starzl Transplantation Institute. We have completed laboratory and preclinical studies, initiated FDA-authorized Phase I/II human clinical trials and established proof of principle for the technology.
It is estimated that liver diseases are among the top ten killer diseases in India, causing lakhs of deaths every year. Besides, there are those who suffer from chronic liver problems, needing recurrent hospitalization and prolonged medical attention, which leaves them physically, mentally, emotionally and financially devastated. On the other hand there are millions of cases of hepatic diseases, which go unreported or are reported when the matters have gone out of hand. |